HempLife Today BETA test of Direct Mail campaign exceeds expected sales and awareness by over 50%; Company plans to expand its Direct Mail marketing and make it a permanent marketing platform throughout 2017

DENVER, CO - (NewMediaWire) - November 14, 2016 - CEO of Ubiquitech Software Corp. (OTC PINK: UBQU), with pending symbol and name change to HempLife Today™, and the management of HempLife Today™ announce positive results of its first BETA test of Direct Mail for its popular CannazALL™ CBD products. 

"In keeping with our commitment to follow through on all of our stated plans, and to follow up with our shareholders and keep them informed of the Company's progress, we offer today's update on our direct mail test that was first announced in late September," James Ballas, CEO.

Direct Mail test exceeded projections by over 50%

After five weeks of results the company is pleased to announce that its first Direct Mail campaign exceeded all stated sales and awareness projections by more than 50%, and that Direct Mail will now become a permanent addition to the HempLife Today™ marketing strategies. Direct Mail will drop approximately every 4-6 weeks to the main consumer lists of HempLife Today™ as well as Subscriber lists that qualify for mailing.

Company expanding its use of Direct Mail in 2017

In addition, the Company is now negotiating with other owners of demographic lists in the pain management and Nutraceutical space that the Company believes will have a profitable response rate to its CannazALL™ CBD products. Expanding Direct Mail to other demographic lists can become an additional profit center to the company and tests of these lists will start in 2017.

"We knew that our direct mail test would prove profitable," says James Ballas, CEO. "But we are extremely happy to report that our direct mail campaigns went deeper into our lists and extracted more sales and awareness than what we had projected. This tells us that not only is this a fantastic addition to our customer promotions, it also shows that we have a lot of room to work with in expanding our direct mail campaigns to other lists and partnership." 

"Direct mail will be a cornerstone of our bottom line as we are able to better target our demographic consumer, educate them about our products, create new long term customers, and do so at a very low acquisition rate," adds Luke Dreyer, technical manager.

Next Direct Mail campaign scheduled for November 28th

The first test of Direct Mail was done the week of September 26th, 2016, and was mailed First Class to current buyers of CannazALL™ CBD products and Subscribers to HempLifeToday™ The Direct Mail campaign displayed the popular line of CannazALL™ CBD products, information about CBD, and a special discount of 30% when using Coupon Code Mail30. The Company currently has its next Direct Mail campaign to its consumer database scheduled for the week of November 28th.

About Ubiquitech (HempLife Today™)

Ubiquitech Software Corp, through its subsidiaries is a dynamic multi-media, multi-faceted corporation utilizing state-of-the-art global internet marketing, Direct Response (DRTV) Television, Radio, and traditional marketing, to drive traffic to the new and emerging multi-billion dollar industries like its subsidiary HempLifeToday.com™.

HempLifeToday™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. Through its network of quality USA growers HempLifeToday.com™ has developed multiple and proprietary CannazALL™ CBD oil products that include: its popular CBD Tinctures, Oils, GelCaps, CBD Powder, Skin Salve, Wax Crumble, and e-liquid, all offered @ www.HempLifeToday.com

This press release contains forward-looking statements. Words such as "expects", "intends'', "believes'', and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company's filings with the OTC Markets Group. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward- looking statements in order to reflect events or circumstances that may arise after the date of this release.